Beta-Blockers in Patients with COPD and Hypertension

Safety and Efficacy

• Cardioselective beta-blockers are not only safe but also beneficial for patients with COPD and hypertension, particularly when using agents with high beta-1 selectivity such as bisoprolol or metoprolol 1, 2
• Recent meta-analyses demonstrate that beta-blockers in patients with COPD and cardiovascular disease are not only safe but also reduce all-cause and in-hospital mortality 1
• Cardioselective beta-blockers may even reduce COPD exacerbations and do not affect the action of bronchodilators 1
• Beta-blockers with low beta-1 selectivity, like atenolol, may worsen pulmonary function 1

Implementation Strategy

• Target heart rate between 60-70 beats/min when using beta-blockers in patients with COPD and hypertension 3

Special Considerations

• Patients with classical pulmonary asthma may still experience worsening of their condition with any beta-blocker, including cardioselective ones 1

Common Pitfalls to Avoid

• Avoiding beta-blockers entirely in COPD patients with hypertension due to unfounded concerns 2
• Failure to distinguish between COPD and asthma, as true asthma remains a stronger contraindication 1